Literature DB >> 14513054

t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.

R Garand1, H Avet-Loiseau, F Accard, P Moreau, J L Harousseau, R Bataille.   

Abstract

Recent studies have shown that two recurrent translocations, t(4;14)(p16;q32) and t(11;14)(q13;q32), define distinct entities with different prognosis in multiple myeloma (MM). We addressed the issue of whether these illegitimate IGH rearrangements could contribute to the morphological heterogeneity of the malignant plasma cells (PC). Bone marrow aspirates of 178 untreated MM cases with successful molecular cytogenetics analysis using fluorescence in situ hybridization were reviewed. PC of 25/48 (52%) patients with t(11;14) exhibited a lymphoplasmacytoid morphology. Moreover, 25/27 (93%) of the cases with this morphological profile bore the t(11;14). In addition, both cytogenetics and morphological subtypes shared higher incidence of nonsecretory MM. In contrast, 17 out of 28 cases (61%) with t(4;14) exhibited PC with diffuse chromatin pattern. Interestingly, both t(4;14) translocation and immature morphology correlated with higher incidence of high tumor mass and chromosome 13 abnormality. In conclusion, our results suggest that a particular morphology can be the signature of chromosomal abnormalities in MM.

Entities:  

Mesh:

Year:  2003        PMID: 14513054     DOI: 10.1038/sj.leu.2403091

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  30 in total

1.  Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Philip R Greipp; Mark R Litzow; Kimberly J Henderson; Scott A Van Wier; Greg J Ahmann; Rafael Fonseca
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

Review 2.  Microarray-based understanding of normal and malignant plasma cells.

Authors:  John De Vos; Dirk Hose; Thierry Rème; Karin Tarte; Jérôme Moreaux; Karéne Mahtouk; Michel Jourdan; Hartmut Goldschmidt; Jean-François Rossi; Friedrich W Cremer; Bernard Klein
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

Review 3.  Genomics in multiple myeloma.

Authors:  Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

4.  Natural history of t(11;14) multiple myeloma.

Authors:  A Lakshman; M Alhaj Moustafa; S V Rajkumar; A Dispenzieri; M A Gertz; F K Buadi; M Q Lacy; D Dingli; A L Fonder; S R Hayman; M A Hobbs; W I Gonsalves; Y L Hwa; P Kapoor; N Leung; R S Go; Y Lin; T V Kourelis; J A Lust; S J Russell; S R Zeldenrust; R A Kyle; S K Kumar
Journal:  Leukemia       Date:  2017-06-27       Impact factor: 11.528

5.  Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.

Authors:  Xiao-Qi Qin; Gang An; Zeng-Jun Li; Lan-Ting Liu; Yan Xu; Lin-Hua Yang; Yan-Ping Ma; Shu-Hui Deng; Wei-Wei Sui; Yu Qin; Xiao-Yan Feng; Mei-Rong Zang; Wen-Juan Yang; Yan-Ru Zhang; Shu-Hua Yi; Ting-Yu Wang; Rui Lv; De-Hui Zou; Yao-Zhong Zhao; Lu-Gui Qiu
Journal:  Blood Adv       Date:  2019-03-12

6.  PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).

Authors:  Kazuyuki Sato; Hirotaka Sakai; Masayuki Kato; Yuji Nishio; Yuka Tsuruoka; Yu Uemura; Satoshi Yokoi; Tasuku Saito; Manabu Matsunawa; Yoshinori Suzuki; Yasushi Isobe; Yasuyuki Inoue; Masatomo Takahashi; Ikuo Miura
Journal:  Int J Hematol       Date:  2015-01-30       Impact factor: 2.490

7.  Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.

Authors:  James R Cook; Marybeth Hartke; James Pettay; Raymond R Tubbs
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 8.  Risk Stratification in Multiple Myeloma in Indian Settings.

Authors:  Rajan Kapoor; Rajiv Kumar; A P Dubey
Journal:  Indian J Hematol Blood Transfus       Date:  2019-12-14       Impact factor: 0.900

9.  Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.

Authors:  Madoka Takimoto; Kohei Ogawa; Yo Kato; Tasuku Saito; Takao Suzuki; Michiko Irei; Yasushi Shibuya; Yoshinori Suzuki; Masayuki Kato; Yasuyuki Inoue; Masatomo Takahashi; Hiroki Sugimori; Ikuo Miura
Journal:  Int J Hematol       Date:  2008-02-16       Impact factor: 2.490

10.  Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma.

Authors:  Amy Heerema-McKenney; James Waldron; Steven Hughes; Fenghuang Zhan; Jeffery Sawyer; Bart Barlogie; John D Shaughnessy
Journal:  Am J Clin Pathol       Date:  2010-02       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.